Why the study?
Does pioglitazone improve histological response and adipose tissue insulin resistance in patients with nonalcoholic steatohepatitis?
Does pioglitazone improve histological response and adipose tissue insulin resistance in patients with nonalcoholic steatohepatitis?
This is the authors' abstract. We don't add key points for this paper.
Patients with NASH have severe Adipo-IR independent of the degree of obesity. Amelioration of Adipo-IR by pioglitazone is closely related to histological improvement and plays an important role during treatment of patients with NASH.
Answers are grounded in this paper and cite their sources.
Pioglitazone-induced improvement in adipose tissue insulin resistance correlates with histological improvement in patients with NASH.
No takes yet. Share an insight, caveat, or question.
Gastaldelli et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: